CYP19A1 and metabolic syndrome: For instance, central obesity and increased adiposity in MetS likely contribute to breast cancer risk through alterations in hormonal regulation leading to over-production of estrogen and intense aromatase activity, ultimately resulting in breast tissue proliferation [42].